PubMed

Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.

Neubauer H, Clare SE, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Vogel U, Sotlar K, Wallwiener D, Kurek R, Fehm T, Cahill MA.

Breast Cancer Res. 2008;10(5):R85. Epub 2008 Oct 15. Erratum in: Breast Cancer Res. 2009;11(1):401. PMID: 18922159 [PubMed - indexed for MEDLINE]Related articlesFree article

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.

Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE.

Breast Cancer Res. 2009;11(1):R11. Epub 2009 Feb 24.PMID: 19239686 [PubMed - indexed for MEDLINE]Related articlesFree article

PGRMC1: a new biomarker for the estrogen receptor in breast cancer.

Craven RJ.

Breast Cancer Res. 2008;10(6):113. Epub 2008 Nov 24.PMID: 19090968 [PubMed - indexed for MEDLINE]Related articlesFree article

The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer.

Mintz PJ, Habib NA, Jones LJ, Giamas G, Lewis JS, Bowen RL, Coombes RC, Stebbing J.

Cancer. 2008 Sep 15;113(6):1489-95.PMID: 18615623 [PubMed - indexed for MEDLINE]Related articlesFree article

Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.

Yamashita H, Nishio M, Kobayashi S, Ando Y, Sugiura H, Zhang Z, Hamaguchi M, Mita K, Fujii Y, Iwase H.

Breast Cancer Res. 2005;7(5):R753-64. Epub 2005 Jul 27.PMID: 16168121 [PubMed - indexed for MEDLINE]Related articlesFree article

Changes in subcellular localisation of MI-ER1 alpha, a novel oestrogen receptor-alpha interacting protein, is associated with breast cancer progression.

McCarthy PL, Mercer FC, Savicky MW, Carter BA, Paterno GD, Gillespie LL.

Br J Cancer. 2008 Aug 19;99(4):639-46. Epub 2008 Jul 29.PMID: 18665173 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.

Brower ST, Ahmed S, Tartter PI, Bleiweiss I, Amberson JB.

Ann Surg Oncol. 1995 Sep;2(5):440-4.PMID: 7496840 [PubMed - indexed for MEDLINE]Related articles

Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor complementary DNA.

Lin VC, Ng EH, Aw SE, Tan MG, Ng EH, Bay BH.

Mol Endocrinol. 2000 Mar;14(3):348-58.PMID: 10707953 [PubMed - indexed for MEDLINE]Related articlesFree article

Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.

Guler G, Huebner K, Himmetoglu C, Jimenez RE, Costinean S, Volinia S, Pilarski RT, Hayran M, Shapiro CL.

Cancer. 2009 Feb 15;115(4):899-908.PMID: 19130459 [PubMed - indexed for MEDLINE]Related articlesFree article

Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.

Järvinen TA, Pelto-Huikko M, Holli K, Isola J.

Am J Pathol. 2000 Jan;156(1):29-35.PMID: 10623650 [PubMed - indexed for MEDLINE]Related articlesFree article

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. Epub 2008 Jan 25.PMID: 18296077 [PubMed - indexed for MEDLINE]Related articles

Estrogen receptor-associated expression of keratinocyte growth factor and its possible role in the inhibition of apoptosis in human breast cancer.

Tamaru N, Hishikawa Y, Ejima K, Nagasue N, Inoue S, Muramatsu M, Hayashi T, Koji T.

Lab Invest. 2004 Nov;84(11):1460-71.PMID: 15311216 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary breast cancer phenotypes associated with propensity for central nervous system metastases.

Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R.

Cancer. 2006 Aug 15;107(4):696-704.PMID: 16826579 [PubMed - indexed for MEDLINE]Related articlesFree article

Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.

Kurbel S.

Med Hypotheses. 2005;64(6):1182-7.PMID: 15823713 [PubMed - indexed for MEDLINE]Related articles

Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.

Neubauer H, Adam G, Seeger H, Mueck AO, Solomayer E, Wallwiener D, Cahill MA, Fehm T.

Climacteric. 2009 Jun;12(3):230-9.PMID: 19340614 [PubMed - indexed for MEDLINE]Related articles

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.

Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR.

JAMA. 2003 Jun 25;289(24):3254-63.PMID: 12824206 [PubMed - indexed for MEDLINE]Related articlesFree article

Significance of immunohistochemical assessment of steroid hormone receptor status for breast cancer patients.

Kurosumi M.

Breast Cancer. 2003;10(2):97-104. Review.PMID: 12736561 [PubMed - indexed for MEDLINE]Related articles

Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection.

Neubauer H, Clare SE, Kurek R, Fehm T, Wallwiener D, Sotlar K, Nordheim A, Wozny W, Schwall GP, Poznanović S, Sastri C, Hunzinger C, Stegmann W, Schrattenholz A, Cahill MA.

Electrophoresis. 2006 May;27(9):1840-52.PMID: 16645950 [PubMed - indexed for MEDLINE]Related articles

Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.

de Candia P, Akram M, Benezra R, Brogi E.

Hum Pathol. 2006 Aug;37(8):1032-41. Epub 2006 May 22.PMID: 16867866 [PubMed - indexed for MEDLINE]Related articles

Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.

Park SS, Kim SW.

Oncol Rep. 2007 Jul;18(1):139-43.PMID: 17549359 [PubMed - indexed for MEDLINE]Related articles